<DOC>
	<DOCNO>NCT02026323</DOCNO>
	<brief_summary>Hyperinsulinemia insulin resistance play key role pathogenesis polycystic ovary syndrome ( PCOS ) . Insulin resistance significantly associate long-term risk metabolic syndrome cardiovascular disease . Acupuncture electrical stimulation rat dihydrotestosterone ( DHT ) -induced PCOS show improve insulin sensitivity . Whether finding translate woman PCOS investigate . Therefore , study aim evaluate whether acupuncture improve insulin sensitivity , ovulation rate quality life woman PCOS . Our hypothesis acupuncture combine manual low-frequency electrical stimulation needle improve insulin resistance , induces ovulation improve quality life .</brief_summary>
	<brief_title>The Effect Acupuncture Insulin Sensitivity Polycystic Ovary Syndrome</brief_title>
	<detailed_description>This prospective observational study . A total 112 woman PCOS insulin resistance recruit randomize two group accord body mass index ( BMI ) , i.e . normal weight ( BMI=18.5-23Kg/m2 ) group overweight obese ( BMI &gt; 23Kg/m2 ) group1 . The acupuncture treatment last six month , 3 time per week , 30 minute per treatment . The primary outcome change insulin sensitivity baseline 6 month acupuncture treatment measure OGTT .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Age ≥ 18 year . 2 . BMI ≥18.5Kg/m2 3 . Confirmed diagnosis PCOS accord Rotterdam criterion : Oligo , amenorrhea ( le 8 cycle per year ) or/clinical biochemical hyperandrogenism and/or polycystic ovarian morphology . 4 . IR define homeostatic model assessment ( HOMAIR : fasting insulin x fast glucose/22.5 ) 2.14 use cut 33 . 5 . No desire child use barrier method contraception 1 year . 6 . Willing sign consent form 1 . With endocrine disorder hyperprolactinemia ( define two prolactin level least one week apart 25 ng/mL great determine local normative value ) , nonclassic congenital adrenal hyperplasia ( 17hydroxyprogesterone &lt; 3nmol/L ) , androgen secreting tumor . 2 . Patients FSH level &gt; 15 mIU/mL . A normal level within last year adequate entry . 3 . Patients uncorrected thyroid disease ( define TSH &lt; 0.2 mIU/mL &gt; 5.5 mIU/mL ) . A normal level within last year adequate entry . 4 . Patients diagnose Type I diabetes , Type I Type II patient receive antidiabetic medication insulin , thiazolidinediones , acarbose , sulfonylurea likely confound effect study medication ; patient currently receive metformin diagnosis Type I Type II diabetes PCOS also specifically exclude . 5 . Patients suspect Cushing 's syndrome . 6 . Use hormonal medication include Chinese Herbal prescription may affect outcome least past 3 month . 7 . Pregnancy within last 6 week . 8 . Postabortion postpartum within last 6 week . 9 . Breastfeeding within last 6 month . 10 . Patients received Acupuncture treatment related PCOS within last 2 month . 11 . Patients undergone bariatric surgery procedure recent past ( &lt; 12 month ) period acute weight loss . 12 . Patients know congenital adrenal hyperplasia . 13 . Not willing give write consent study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>